Courier Therapeutics Competitors and Similar CompaniesClear all
Courier Therapeutics's competitors and similar companies include ABL Bio, Agios Pharmaceuticals, Accent Therapeutics and Nkarta Therapeutics.
 Courier Therapeutics Courier Therapeutics is a biotechnology company providing a cytotoxic-lymphocyte targeting therapy platform. |  ABL Bio ABL Bio is a biotech research company focusing on the development of therapeutic drugs for immuno-oncology and neurodegenerative disease. |  Agios Pharmaceuticals Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism. |  Accent Therapeutics Accent Therapeutics is a biopharmaceutical company engaged in the development of therapies for cancer. |  Nkarta Therapeutics Nkarta Therapeutics is a biopharmaceutical company developing engineered natural killer (NK) cell therapies for the treatment of cancer. | |
Founding Date | Founding Date 2015 | Founding Date 2016 | Founding Date 2008 | Founding Date 2017 | Founding Date 2015 |
Type | Type Private | Type Private | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Houston, US HQ Houston, US | Locations HQ | Locations Cambridge, US HQ | Locations Lexington, US HQ | Locations South San Francisco, US HQ |
Employees | Employees 1 | Employees 615% increase | Employees 53611% increase | Employees 353% increase | Employees 1594% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 2.7 b | Valuation ($) N/A | Valuation ($) 240.6 m |
Financial | |||||
Net income | Net income N/A | Net income N/A | Net income ($412.8m) (FY, 2025) | Net income N/A | Net income ($104.1m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 65m (almost 8 years ago) | Latest funding round N/A | Latest funding round $ 63m (about 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 90.8m | Total funding raised N/A | Total funding raised $ 103m | Total funding raised $ 125m |
For sources of this data, please see the company profile
View Company Profiles
ABL Bio
HQ
Employees
61↑ 5% increase
ABL Bio is a biotech research company focusing on the development of therapeutic drugs for immuno-oncology and neurodegenerative disease.
View companyAgios Pharmaceuticals
HQ
Cambridge, US
Employees
536↑ 11% increase
Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.
View companyAccent Therapeutics
HQ
Lexington, US
Employees
35↑ 3% increase
Accent Therapeutics is a biopharmaceutical company engaged in the development of therapies for cancer.
View companyNkarta Therapeutics
HQ
South San Francisco, US
Employees
159↓ 4% decrease
Nkarta Therapeutics is a biopharmaceutical company developing engineered natural killer (NK) cell therapies for the treatment of cancer.
View company